ACADIA Pharmaceuticals Inc.

8-K Director or officer change; Shareholder vote results May 29, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Director or officer change; Regulation FD disclosure May 1, 2026 8-K Director or officer change Mar 5, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Director or officer change Nov 3, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Other events Jun 10, 2025 8-K Shareholder vote results May 29, 2025 8-K Entered a material agreement; Other events May 20, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Amended charter or bylaws Apr 16, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Completed an acquisition or disposition Dec 11, 2024 8-K Director or officer change Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Director or officer change Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Director or officer change; Shareholder vote results May 29, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Other events Mar 11, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Results of operations (earnings release) Feb 27, 2024 8-K Director or officer change Jan 31, 2024 8-K Other events Nov 21, 2023 10-Q Quarter ended 2023-09-30 Nov 3, 2023 8-K Results of operations (earnings release) Nov 2, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release) Aug 2, 2023